Mandate

Acquisition of Alvedon approved

April 07, 2009

The Swedish Competition Authority has, following an in-depth investigation, on 3 April 2009 cleared GlaxoSmithKline’s acquisition of a portfolio of drugs, including i.a. the brand Alvedon, from AstraZeneca.

Alvedon is the leading painkiller brand in Sweden. GlaxoSmithKline controlled already prior to the acquisition Panodil, one of the main competing brands. The transaction was notified by the parties on 22 December 2008.
The Competition Authority carried out an extensive market investigation and retained external expertise to simulate the effects of the combination.

“Although the transaction involved a strong market position in painkillers based on paracetamol, the Competition Authority could eventually conclude that the transaction did not significantly impede the existence or development of effective competition. The Competition Authority’s decision is, of course, satisfactory for the parties but also of principle importance”, says Johan Karlsson, responsible partner for Vinge’s competition team, who acted for AstraZeneca.

“It is one of the few cases where efficiencies made a real difference for the outcome. The decision also shows that the Competition Authority, which it should do, could also take into account future changes in the market place, in this case the liberalization of the pharmaceutical market.”

Vinge advised AstraZeneca. Vinge’s competition team included Johan Karlsson (responsible partner), Mattias Ganslandt (economist), Per Karlsson (counsel), Peter Alstergren (associate) and Carl Johan Sundqvist (associate).   

Related

Vinge advises Karl Hedin and the minority owners in connection with the sale of AS Toftan to Combiwood

Vinge has advised Karl Hedin and the minority owners in connection with the sale of AS Toftan to Combiwood Grupp OÜ (“Combiwood”).
May 22, 2025

Vinge has advised the FEA Group, which includes Freys Hyrverk and Stockholm Limousine Service, in connection with its merger with Inclusion Services International

The merger strengthens the new FEA Group’s capacity and service offering, which includes everything from comprehensive travel planning and hotel bookings to security-classified passenger transport and risk assessments. According to management, the newly formed group will have a unique position in the Swedish market with the opportunity to introduce new transport and security solutions that are currently unmatched in the country.
May 21, 2025

Vinge advises EHF Invest on its public offer for Real Fastigheter

EHF Invest AB has made a public offer for all shares in Real Fastigheter AB (publ).
May 21, 2025